Ranolazine
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
71205-868 -
Package NDC
71205-868-00 -
Package NDC
71205-868-30 -
Package NDC
71205-868-55 -
Package NDC
71205-868-60 -
Package NDC
71205-868-72 -
Package NDC
71205-868-78 -
Package NDC
71205-868-90 -
Application number
ANDA211829 -
SPL ID
278d3fa3-3304-43dc-8a2a-a463c8ae9e9d -
SPL set ID
989e1688-a0b5-4297-bf91-234de2a0b445 -
UNII
A6IEZ5M406 -
RxCUI
616749 -
RxCUI
728231
What the source publishes
- Labeler
- Proficient Rx LP
- Active ingredients
- Ranolazine
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Ranolazine",
"splId": "278d3fa3-3304-43dc-8a2a-a463c8ae9e9d",
"labels": [
{
"setId": "989e1688-a0b5-4297-bf91-234de2a0b445",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=989e1688-a0b5-4297-bf91-234de2a0b445",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=989e1688-a0b5-4297-bf91-234de2a0b445"
}
],
"routes": [
"ORAL"
],
"labeler": "Proficient Rx LP",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-868-00)",
"package_ndc": "71205-868-00",
"identifierStatus": "well-formed",
"marketing_start_date": "20211217"
},
{
"sample": false,
"description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-868-30)",
"package_ndc": "71205-868-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20211217"
},
{
"sample": false,
"description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-868-55)",
"package_ndc": "71205-868-55",
"identifierStatus": "well-formed",
"marketing_start_date": "20211217"
},
{
"sample": false,
"description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-868-60)",
"package_ndc": "71205-868-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20211217"
},
{
"sample": false,
"description": "120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-868-72)",
"package_ndc": "71205-868-72",
"identifierStatus": "well-formed",
"marketing_start_date": "20211217"
},
{
"sample": false,
"description": "180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-868-78)",
"package_ndc": "71205-868-78",
"identifierStatus": "well-formed",
"marketing_start_date": "20211217"
},
{
"sample": false,
"description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-868-90)",
"package_ndc": "71205-868-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20211217"
}
],
"productId": "71205-868_278d3fa3-3304-43dc-8a2a-a463c8ae9e9d",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED, EXTENDED RELEASE",
"productNdc": "71205-868",
"deaSchedule": null,
"genericName": "Ranolazine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "RANOLAZINE",
"strength": "1000 mg/1"
}
],
"applicationNumber": "ANDA211829",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20210824",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175427",
"N0000190114",
"N0000185503",
"N0000182137",
"N0000187061"
],
"upc": [
"0371205868789",
"0371205867782"
],
"unii": [
"A6IEZ5M406"
],
"rxcui": [
"616749",
"728231"
],
"spl_set_id": [
"989e1688-a0b5-4297-bf91-234de2a0b445"
],
"pharm_class_epc": [
"Anti-anginal [EPC]"
],
"pharm_class_moa": [
"Cytochrome P450 3A Inhibitors [MoA]",
"P-Glycoprotein Inhibitors [MoA]",
"Cytochrome P450 2D6 Inhibitors [MoA]",
"Organic Cation Transporter 2 Inhibitors [MoA]"
],
"manufacturer_name": [
"Proficient Rx LP"
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:71205-868_278d3fa3-3304-43dc-8a2a-a463c8ae9e9d"